Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancer

The aim of the study was to evaluate the response, survival advantage and toxicity profile of gemcitabine-carboplatin combination cytotoxic chemotherapy in patients with locally advanced and metastatic non-small cell lung cancer (NSCLC).